Allspring Global Investments’s Acadia Healthcare ACHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-98
Closed -$6.21K 1754
2024
Q3
$6.21K Buy
98
+50
+104% +$3.61K ﹤0.01% 2147
2024
Q2
$3.24K Buy
+48
New +$3.35K ﹤0.01% 2259
2023
Q1
Sell
-58,667
Closed -$4.83M 2762
2022
Q4
$4.83M Buy
58,667
+40,237
+218% +$3.32M 0.01% 987
2022
Q3
$1.44M Buy
+18,430
New +$1.47M ﹤0.01% 1332
2022
Q2
Sell
-60,672
Closed -$3.98M 2676
2022
Q1
$3.98M Sell
60,672
-7,376
-11% -$428K 0.01% 1240
2021
Q4
$4.13M Buy
+68,048
New +$4.06M ﹤0.01% 1247

Other funds holding ACHC

Allspring Global Investments's ACHC Position: Q4 2024 in Review

Allspring Global Investments sold out of Acadia Healthcare (ACHC) in Q4 2024, closing a stake of 98 shares — an estimated $6.21K sold.

Allspring Global Investments first reported a position in ACHC in Q4 2021 and held it in 6 quarters. The position peaked at $4.83M in Q4 2022. 306 funds tracked by Wall St. Rank hold ACHC as of Q4 2024.

  • Allspring Global Investments reported no remaining Acadia Healthcare position as of Q4 2024 after selling out during the quarter.
  • Allspring Global Investments sold 98 Acadia Healthcare shares in Q4 2024, an estimated $6.21K.
  • Allspring Global Investments first reported a position in Acadia Healthcare in Q4 2021 and held it in 6 quarters.
  • Allspring Global Investments's Acadia Healthcare position peaked at $4.83M in Q4 2022.
  • 306 funds tracked by Wall St. Rank held Acadia Healthcare as of Q4 2024.

Based on Allspring Global Investments's 13F filing for Q4 2024, filed 29 Jan 2025.